Biopixlar AER

Biopixlar AER

Groundbreaking Applications in Research & Medicine
Biopixlar AER lets you create detailed research models containing multiple different cell types with full control of the tissue construction process.

The open-volume microfluidic technology makes Biopixlar AER well suited for applications in precision medicine, drug discovery and medical research involving scarce and valuable materials, such as patient-derived cells.

The Power of Single-Cell Bioprinting in a Compact Format
Biopixlar AER brings you the full power of single-cell bioprinting in a compact and portable package. Biopixlar AER is all-in-one discovery platform that fits inside a standard laminar flow hood that lets you position cells in three dimensions with high precision.

Biopixlar AER empowers researchers to create tissues for research, drug development and regenerative medicine and to push the boundaries of science.

Category:

Description

Biopixlar AER is Fluicell’s compact single-cell bioprinting platform that fits into your fume hood or biosafety cabinet. Biopixlar AER is designed for easy workflow integration, bringing bioprinting to where you need it.

HIGH PRECISION AND RESOLUTION

Biopixlar AER is powered by Fluicell’s open volume microfluidic technology that gives you full control over the bioprinting process, down to the level of individual cells. The exchangeable microfluidic printhead lets you deposit cells right where you want them with micrometer precision. This makes it possible to create everything from single-cell arrays to detailed tissues containing multiple different cell types.

 

 

BUILT FOR CHALLENGING CONDITIONS

Biopixlar AER’s automation and remote control capabilities makes the platform well suited for use in complex and harsh environments where direct access is not possible. The robust yet flexible design makes it even possible to adapt Biopixlar AER for use in space or in deep-sea environments.

 

 

95 % CELL VIABILITY

Biopixlar AER requires no bioink to print cells. This, combined with the open volume bioprinting technology, creates a cell-friendly environment and ensures a high cell viability in the bioprinted tissues.

 

 

 

LOW SAMPLE VOLUME REQUIREMENTS

Biopixlar AER’s microfluidic bioprinting technology requires very little sample volumes, making it the ideal choice for uses involving scarce and valuable materials, such as applications within personalized medicine using patient-derived material.

Literature

Download the Biopixlar AER brochure